45 studies found for:    Friedreich's Ataxia
Show Display Options
Rank Status Study
21 Completed A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Deferiprone oral solution 100mg/mL;   Drug: Deferiprone oral solution 100 mg/mL
22 Not yet recruiting (+) Epicatechin to Treat Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: (+)-Epicatechin
23 Completed Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)
Condition: Friedreich's Ataxia
Intervention: Drug: Idebenone
24 Recruiting A First in Human Study of RT001 in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: RT001;   Drug: RT001 comparator
25 Completed A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
Condition: Friedreich's Ataxia
Interventions: Drug: idebenone;   Drug: Placebo
26 Completed Efficacy Study of Epoetin Alfa in Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: Epoetin alfa;   Drug: Placebo
27 Recruiting Biomarkers in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention:
28 Completed Safety Study of Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
29 Completed Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: Epoetin alfa
30 Completed Iron-Chelating Therapy and Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Iron chelating intervention
31 Active, not recruiting Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Placebo;   Drug: EPI-743 400 mg;   Drug: EPI-743 200 mg
32 Completed
Has Results
Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: EGb 761 120 mg;   Drug: Placebo
33 Completed Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: VP 20629;   Drug: Placebo
34 Completed An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: bupropion & Citalopram;   Drug: Bupropion & Placebo;   Drug: Placebo & Citalopram;   Drug: Placebo & Placebo
35 Completed Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: alpha-tocopherolquinone (A0001);   Drug: placebo
36 Completed Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)
Condition: Freidreich's Ataxia
Intervention: Drug: idebenone
37 Unknown  A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients
Condition: Friedreich Ataxia.
Intervention: Drug: gamma interferon
38 Active, not recruiting Effect of Nicotinamide in Friedreich's Ataxia
Condition: Neurodegenerative Disorders
Intervention: Drug: nicotinamide
39 Active, not recruiting Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
Conditions: Spinocerebellar Ataxia - All Sub-types;   Friedreich's Ataxia
Intervention: Other: Ataxia rating scale
40 Completed Efficacy of Riluzole in Hereditary Cerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Drug: riluzole;   Drug: Placebo comparator

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Indicates status has not been verified in more than two years